Caffeine regulates splicing of cancer-related genes: dissecting the mechanism

咖啡因调节癌症相关基因的剪接:剖析其机制

基本信息

项目摘要

DESCRIPTION (provided by applicant): Alternative splicing of pre-mRNA contributes significantly to human proteomic complexity and functional diversity, playing a key role in developmental decisions, gene expression regulation and, when aberrant, in human disease onset. Importantly, over 1000 splicing variants have been associated with the cancer phenotype. Although the functional analysis of these variants and their possible role in cancer is still in its infancy, their potential importance as cancer biomarkers/therapeutic targets has garnered much interest. We now present a substantial body of preliminary data showing that caffeine, a highly consumed stimulant in the human diet, induces alternative splicing of a large subset of cancer-related genes including the tumor suppressor KLF6. Using KLF6 as a prototype, we have shown that this induction is rapid and reversible and occurs at the level of splicing rather than differential stability. We also demonstrate that the four classic caffeine signaling pathways have little if any role in caffeine-induced alternative splicing, indicating that a novel molecular mechanism is operative. Importantly, since the previous submission we have found that alternative splicing of KLF6 is regulated by the SR protein SC35, and that this protein is induced by caffeine. We now hypothesize that caffeine regulates alternative splicing, at least in part, by the induction of SC35, and may mimic an endogenous pathway aberrantly activated in cancer cells. To further dissect the impact of caffeine on the splicing of cancer-related genes, we now propose to: 1) Investigate the role of SC35 in caffeine-mediated alternative splicing, using KLF6 as a prototype; 2) Investigate the interaction of splicing factors with KLF6 ESS-1 and ISE-1 in vitro and in vivo, and interrogate a model for regulation of KLF6 splicing by SC35: 3) Determine the mechanism by which caffeine elevates SC35 and 4) Determine whether caffeine induces "cancer-specific" splice variants in normal tissues in vivo. Our observation that caffeine can regulate alternative splicing of a variety of genes involved in the cancer phenotype is both highly significant and timely. We expect that these studies will result in the identification of elements/factors/pathways that are common to the splicing regulation of this cancer gene subset. We also expect to determine whether high caffeine consumption can induce cancer-related splice variants in normal cells in vivo, resulting in transient expression that may confound both biomarker analysis and targeted therapy.
描述(由申请人提供):前MRNA的替代剪接对人类蛋白质组学的复杂性和功能多样性有显着贡献,在发育决策,基因表达调控以及异常时在人类疾病发作中起关键作用。重要的是,超过1000种剪接变体与癌症表型有关。尽管对这些变异的功能分析及其在癌症中的可能作用仍处于起步阶段,但作为癌症生物标志物/治疗靶标的潜在重要性引起了人们的兴趣。现在,我们提供了大量的初步数据,表明咖啡因是人类饮食中高度消耗的兴奋剂,可诱导大量与癌症相关基因的替代剪接,包括肿瘤抑制器KLF6。使用KLF6作为原型,我们表明这种诱导是快速且可逆的,并且发生在剪接水平而不是差异稳定性的水平上。我们还证明,四种经典的咖啡因信号通路在咖啡因诱导的替代剪接中几乎没有任何作用,这表明一种新型的分子机制是可操作的。重要的是,由于先前的提交,我们发现KLF6的替代剪接受SR蛋白SC35的调节,并且该蛋白是由咖啡因诱导的。现在,我们假设咖啡因至少部分通过诱导SC35来调节替代剪接,并且可能模仿内源性途径在癌细胞中异常激活。为了进一步剖析咖啡因对癌症相关基因剪接的影响,我们现在建议:1)研究SC35在咖啡因介导的替代剪接中的作用,使用KLF6作为原型; 2)研究剪接因子与KLF6 ESS-1和ISE-1在体外和体内的相互作用,并通过SC35:3)询问一个模型,以调节KLF6剪接的模型,以确定咖啡因升高SC35和4的机制,该机制升高SC35和4)确定咖啡因是否诱导“癌症特异性” splice splice splice in Prancorce in normal in normal in vivo in Vivo。我们的观察结果是,咖啡因可以调节癌症表型涉及的各种基因的替代剪接既有意义又及时。我们预计这些研究将导致鉴定该癌症基​​因子集的剪接调节所共有的元素/因素/途径。我们还期望确定高咖啡因消耗是否可以诱导体内正常细胞中与癌症相关的剪接变异,从而导致瞬时表达,这可能会使生物标志物分析和靶向治疗混淆。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KATHLEEN W. SCOTTO其他文献

KATHLEEN W. SCOTTO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KATHLEEN W. SCOTTO', 18)}}的其他基金

NRSA Training
国家安全局培训
  • 批准号:
    9890030
  • 财政年份:
    2019
  • 资助金额:
    $ 8.81万
  • 项目类别:
NRSA Training
国家安全局培训
  • 批准号:
    10582732
  • 财政年份:
    2019
  • 资助金额:
    $ 8.81万
  • 项目类别:
NRSA Training
国家安全局培训
  • 批准号:
    10361305
  • 财政年份:
    2019
  • 资助金额:
    $ 8.81万
  • 项目类别:
NRSA Training
国家安全局培训
  • 批准号:
    10115155
  • 财政年份:
    2019
  • 资助金额:
    $ 8.81万
  • 项目类别:
Caffeine regulates splicing of cancer-related genes: dissecting the mechanism
咖啡因调节癌症相关基因的剪接:剖析其机制
  • 批准号:
    8700869
  • 财政年份:
    2007
  • 资助金额:
    $ 8.81万
  • 项目类别:
Caffeine regulates splicing of cancer-related genes: dissecting the mechanism
咖啡因调节癌症相关基因的剪接:剖析其机制
  • 批准号:
    7407446
  • 财政年份:
    2007
  • 资助金额:
    $ 8.81万
  • 项目类别:
Caffeine regulates splicing of cancer-related genes: dissecting the mechanism
咖啡因调节癌症相关基因的剪接:剖析其机制
  • 批准号:
    7268167
  • 财政年份:
    2007
  • 资助金额:
    $ 8.81万
  • 项目类别:
Caffeine regulates splicing of cancer-related genes: dissecting the mechanism
咖啡因调节癌症相关基因的剪接:剖析其机制
  • 批准号:
    7578287
  • 财政年份:
    2007
  • 资助金额:
    $ 8.81万
  • 项目类别:
Caffeine regulates splicing of cancer-related genes: dissecting the mechanism
咖啡因调节癌症相关基因的剪接:剖析其机制
  • 批准号:
    7768468
  • 财政年份:
    2007
  • 资助金额:
    $ 8.81万
  • 项目类别:
NJ Center for Clinical and Translational Sciences
新泽西临床和转化科学中心
  • 批准号:
    7216033
  • 财政年份:
    2006
  • 资助金额:
    $ 8.81万
  • 项目类别:

相似国自然基金

髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
  • 批准号:
    82372496
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
利用碱基编辑器治疗肥厚型心肌病的动物模型研究
  • 批准号:
    82300396
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
利用小型猪模型评价动脉粥样硬化易感基因的作用
  • 批准号:
    32370568
  • 批准年份:
    2023
  • 资助金额:
    50.00 万元
  • 项目类别:
    面上项目
丁苯酞通过调节细胞异常自噬和凋亡来延缓脊髓性肌萎缩症动物模型脊髓运动神经元的丢失
  • 批准号:
    82360332
  • 批准年份:
    2023
  • 资助金额:
    31.00 万元
  • 项目类别:
    地区科学基金项目
APOBEC3A驱动膀胱癌发生发展的动物模型及其机制研究
  • 批准号:
    82303057
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Pharmacodynamic Biomarker of Myotonic Dystrophy
强直性肌营养不良的药效生物标志物
  • 批准号:
    10651049
  • 财政年份:
    2023
  • 资助金额:
    $ 8.81万
  • 项目类别:
A Novel Long Noncoding RNA Associated with Systemic Lupus Erythematosus Pathogenesis
一种与系统性红斑狼疮发病机制相关的新型长非编码RNA
  • 批准号:
    10725130
  • 财政年份:
    2022
  • 资助金额:
    $ 8.81万
  • 项目类别:
A Novel Long Noncoding RNA Associated with Systemic Lupus Erythematosus Pathogenesis
一种与系统性红斑狼疮发病机制相关的新型长非编码RNA
  • 批准号:
    10537564
  • 财政年份:
    2022
  • 资助金额:
    $ 8.81万
  • 项目类别:
Linking TBI secondary injuries to FTLD- and ALS-like neurodegeneration
TBI 继发性损伤与 FTLD 和 ALS 样神经变性的联系
  • 批准号:
    10309060
  • 财政年份:
    2021
  • 资助金额:
    $ 8.81万
  • 项目类别:
Cellular Heterogeneity and Aging in MDS and AML
MDS 和 AML 中的细胞异质性和衰老
  • 批准号:
    10013078
  • 财政年份:
    2021
  • 资助金额:
    $ 8.81万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了